Denosumab is marketed under which brand name?

Prepare for the CMS II Rheumatology E1 Exam. Enhance your skills with engaging flashcards, detailed explanations, and multiple-choice questions. Get exam-ready today!

Multiple Choice

Denosumab is marketed under which brand name?

Explanation:
Denosumab is marketed as Prolia for osteoporosis. It’s a monoclonal antibody that inhibits RANKL, reducing osteoclast formation and bone resorption. The other names refer to different drugs: Forteo is teriparatide (a PTH analog that stimulates bone formation), Boniva is ibandronate and Actonel is risedronate (both bisphosphonates that slow bone resorption). There’s also Xgeva for denosumab used in cancer with bone metastases, but for osteoporosis the brand you’d see is Prolia.

Denosumab is marketed as Prolia for osteoporosis. It’s a monoclonal antibody that inhibits RANKL, reducing osteoclast formation and bone resorption. The other names refer to different drugs: Forteo is teriparatide (a PTH analog that stimulates bone formation), Boniva is ibandronate and Actonel is risedronate (both bisphosphonates that slow bone resorption). There’s also Xgeva for denosumab used in cancer with bone metastases, but for osteoporosis the brand you’d see is Prolia.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy